Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-224-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
A key oral acute toxicity study according to OECD 401 test method was performed in male rats, leading to a LD50 =4650 mg test mat./kg bw. A key dermal acute toxicity study according to OECD 402 test method was performed in male rabbits, demonstrating a LD50 > 2500 mg test mat./kg bw. Acute inhalation toxicity was waived based on exposure reasons.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1957
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study non-GLP with limited data on study design, however the study was conducted to state of the art methods at that time period. The study is therefore considered adequate, reliable and relevant.
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- 7 days observation period
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- other: albino
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Not provided
- Route of administration:
- oral: unspecified
- Vehicle:
- water
- Remarks:
- 20% aqueous solution
- Doses:
- 10.0 g/kg, 5.0 g/kg, 2.5 g/kg, 1.25 g/kg
- No. of animals per sex per dose:
- 5 males per dose
- Control animals:
- no
- Details on study design:
- The product (Aerosol AY) was administered to groups of young, male albino rats (5 animals per group) as an 20% aqueous solution at dosages ranging from 1.25 g/kg to 10 g/kg.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 4 650 mg/kg bw
- Based on:
- act. ingr.
- 95% CL:
- > 3 000 - < 7 250
- Mortality:
- Death occurred fairly promptly following lethal doses, usually within one-half to one hour.
From the number and distribution of deaths, the LD50 of the product is calculated as 4650 (3000-7250) mg/kg bw. - Clinical signs:
- other: Survivors exhibited varying degrees of depression for periods up to 24 hours following the dose, but thereafter maintained a normal appearance and behavior for remainder of a 7-day observation period.
- Gross pathology:
- They were sacrificed at the end of this time, and gross autopsy disclosed no pathology that could be attributed to the dose.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 of Aerosol AY dosed as a 20% aqueous solution to male albino rats is 4.65 (3.00-7.25) g/kg .
- Executive summary:
The test item was administered to groups of young, male albino rats (5 animals per group) as an 20% aqueous solution at dosages ranging from 1.25 g/kg to 10 g active ingredient/kg bw. Death occurred fairly promptly following lethal doses, usually within one-half to one hour, and post-mortem examination revealed moderate to severe hemorrhage of the entire gastrointestinal tract. From the number and distribution of deaths, the LD50 of the product is calculated as 4.65 (3.00-7.25) g/kg. Survivors exhibited varying degrees of depression for periods up to 24 hours following the dose, but thereafter maintained a normal appearance and behavior for remainder of a 7-day observation period. They were sacrificed at the end of this time, and gross autopsy disclosed no pathology that could be attributed to the dose.
Reference
Table 1: Aerosol AY: Single Dose to Male Albino Rats by Mouth. Product Administered as a Solution in Water, 1 mL= 0.2 g.
Animal Number |
Body weight in Grams |
Weight Change in 7 Days |
Dosage in g/kg |
Dose in Grams |
Dose in mL of Solution |
Days to Death |
R 9956 |
93 |
- |
10.0 |
0.94 |
4.7 |
<1 |
R 9957 |
107 |
- |
10.0 |
1.08 |
5.4 |
<1 |
R 9958 |
111 |
- |
10.0 |
1.12 |
5.6 |
<1 |
R 9959 |
110 |
- |
10.0 |
1.10 |
5.5 |
<1 |
R 9960 |
102 |
- |
10.0 |
1.02 |
5.1 |
<1 |
|
|
|
|
|
|
|
R 9961 |
110 |
- |
5.0 |
0.55 |
2.75 |
<1 |
R 9962 |
106 |
- |
5.0 |
0.53 |
2.65 |
<1 |
R 9965 |
105 |
20 |
5.0 |
0.53 |
2.63 |
S |
R 9966 |
98 |
28 |
5.0 |
0.49 |
2.45 |
S |
R 9967 |
102 |
34 |
5.0 |
0.51 |
2.55 |
S |
|
|
|
|
|
|
|
R 9968 |
103 |
- |
2.5 |
0.26 |
1.29 |
<1 |
R 9969 |
104 |
34 |
2.5 |
0.26 |
1.30 |
S |
R 9970 |
106 |
20 |
2.5 |
0.27 |
1.33 |
S |
R 9971 |
98 |
37 |
2.5 |
0.25 |
1.23 |
S |
R 9972 |
114 |
49 |
2.5 |
0.29 |
1.43 |
S |
|
|
|
|
|
|
|
R 9877 |
90 |
28 |
1.25 |
0.11 |
0.57 |
S |
R 9880 |
92 |
30 |
1.25 |
0.12 |
0.58 |
S |
R 9881 |
93 |
35 |
1.25 |
0.12 |
0.59 |
S |
R 9884 |
90 |
26 |
1.25 |
0.11 |
0.57 |
S |
R 9890 |
94 |
2 |
1.25 |
0.12 |
0.59 |
S |
S= Survived
LD50= 4.65 (3.00-7.25) g/kg
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 4 650 mg/kg bw
- Quality of whole database:
- Reliable
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1957
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study non-GLP with limited data on study design, however the study was conducted to state of the art methods at that time period. The study is therefore considered adequate, reliable and relevant.
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- other: albino
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Not provided
- Type of coverage:
- occlusive
- Vehicle:
- other: Aerosol AY was moistened with sufficient water to form a paste
- Details on dermal exposure:
- TEST SITE
- Area of exposure: closely clipped skin of the abdomen
- Type of wrap if used: a cuff of polyethylene film which encircled the trunk of the animal
REMOVAL OF TEST SUBSTANCE
- Washing (if done):
- Time after start of exposure:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2.5 g/kg, 5 g/kg and 10 g/kg
- For solids, paste formed: yes
VEHICLE
- Amount(s) applied (volume or weight with unit): The dose was moistened with sufficient water to form a paste. - Duration of exposure:
- 24 hours
- Doses:
- dosages of 2.5g/kg, 5 g/kg and 10 g/kg ; Aerosol AY was moistened with sufficient water to form a paste.
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 7 days
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 2 500 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Two out of five rabbits died at a dosage of 10 g/kg and one out of five succumbed at 5 g/kg.
- Clinical signs:
- other: Moderate to severe erythema and edema were present in all cases at the end of the exposure period. The edema was greatly reduced by the second day after dosing, and has subsided almost completely by the third day. Erythema persisted to a slight degree a d
- Other findings:
- Moderate to severe erythema and edema were present in all cases at the end of the exposure period. The edema was greatly reduced by the second day after dosing, and has subsided almost completely by the third day. Erythema persisted to a slight degree a day or two longer.
Apart from varying degrees of depression, most animals gave no evidence of systemic toxicity on the day following that of application of the dose. On the second day, however, one animal of the 10 g/kg group exhibited extreme depression and apparent loss of control of the hind legs which were fully extended anteriorly. Altough the animal could hold his head erect, it refused or was unable to attempt movement when placed on the floor. This condition is believed to have been the result of some incidental traumatic injury rather than a consequence of the dose. The animal died on the fourth day. There was another death in the 10 g/kg group, this on the sixth day, and a death at the 5 g/kg level on the sixth day. An LD50 of the product cannot be calculated from these results, although it is certainly greater than 2.5 g/kg. Survivors were observed for a total of seven days after that of the dose, and were then sacrificed. No significant pathology was find by gross autopsy. - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Application of dosages of 2.5 g/kg to 10 g/kg as an aqueous paste to the clipped skin of rabbits for 24 hours led to moderate to severe erythema and edema which persisted for three to four days. Two out of five rabbits died at a dosage of 10 g/kg and one out of five succumbed at 5 g/kg.
LD50 > 2500 mg/kg bw. - Executive summary:
Three groups of male albino rabbits, 5 animals per group, received single applications of the test item on the closely-clipped skin of the abdomen at dosages of 2.5 g/kg, 5 g/kg and 10 g active ingredient/kg bw, respectively.
The dose was moistened with sufficient water to form a paste, and retained in contact with the skin for 24 hours by means of a cuff of polyethylene film which was encircled the trunk of the animal. At the end of the period of exposure, the cuff and any excess of the dose were removed, and the skin examined for primary irritation.
Moderate to severe erythema and edema were present in all cases at the end of the exposure period. The edema was greatly reduced by the second day after dosing, and has subsided almost completely by the third day. Erythema persisted to a slight degree a day or two longer.
Apart from varying degrees of depression, most animals gave no evidence of systemic toxicity on the day following that of application of the dose. On the second day, however, one animal of the 10 g/kg group exhibited extreme depression and apparent loss of control of the hind legs which were fully extended anteriorly. Although the animal could hold his head erect, he refused or was unable to attempt movement when placed on the floor. This condition is believed to have been the result of some incidental traumatic injury rather than a consequence of the dose. The animal died on the fourth day. There was another death in the 10 g/kg group, this on the sixth day, and a death at the 5 g/kg level on the sixth day. An LD50 of the product cannot be calculated from these results, although it is certainly greater than 2.5 g/kg. Survivors were observed for a total of seven days after that of the dose, and were than sacrificed. No significant pathology was find by gross autopsy.
Reference
Table 1: Aerosol AY: Single Doses to Male Albino Rabbits by Skin Application. Product Administered as an Aqueous Paste Under Polyethylene Film for 24 Hours.
Animal Number |
Body Weight in Grams |
Weight Change in 7 Days |
Dosages in g/kg |
Dose in Grams |
Days to Death |
H 745 |
3075 |
-44 |
10.0 |
30.8 |
S |
H 746 |
3250 |
-645 |
10.0 |
32.5 |
S |
H 747 |
3312 |
- |
10.0 |
33.1 |
6 |
H 748 |
3281 |
- |
10.0 |
32.8 |
4 |
H 749 |
3301 |
-583 |
10.0 |
33.0 |
S |
|
|
|
|
|
|
H 794 |
3203 |
-107 |
5.0 |
16.1 |
S |
H 795 |
3383 |
-245 |
5.0 |
16.9 |
S |
H 797 |
3668 |
-636 |
5.0 |
18.3 |
S |
H 798 |
3625 |
- |
5.0 |
18.1 |
6 |
H 799 |
3802 |
-390 |
5.0 |
19.0 |
S |
|
|
|
|
|
|
H 804 |
3000 |
-532 |
2.5 |
7.5 |
S |
H 805 |
3520 |
-331 |
2.5 |
8.8 |
S |
H 806 |
3270 |
-257 |
2.5 |
8.2 |
S |
H 807 |
3675 |
-199 |
2.5 |
9.2 |
S |
H 808 |
3500 |
-386 |
2.5 |
8.8 |
S |
S= Survived
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 500 mg/kg bw
- Quality of whole database:
- Reliable
Additional information
Acute oral toxicity
In a key acute oral toxicity study (Shaffer et al., 1957a) the test item was administered to groups of young, male albino rats (5 animals per group) as an 20% aqueous solution at dosages of 1250, 2500, 5000 and 10000 mg active ingredient/kg bw. Death occurred fairly promptly following lethal doses, usually within one-half to one hour, and post-mortem examination revealed moderate to severe hemorrhage of the entire gastrointestinal tract. From the number and distribution of deaths, the LD50 is calculated as 4650 mg/kg bw. Survivors exhibited varying degrees of depression for periods up to 24 hours following the dose, but thereafter maintained a normal appearance and behavior for remainder of a 7-day observation period. Gross autopsy disclosed no pathology that could be attributed to the dose.
In conclusion, based on the registered substance, there is no acute oral toxicity hazard as LD50 is >2000 mg/kg bw (active ingredient).
Acute dermal toxicity
In a key acute dermal toxicity study (Shaffer et al., 1957a) three groups of male albino rabbits, 5 animals per group, received single applications of the test item on the closely-clipped skin of the abdomen at dosages of 2500, 5000 and 10000 mg active ingredient/kg bw, respectively. The dose was moistened with sufficient water to form a paste, and retained in contact with the skin for 24 hours by means of a cuff of polyethylene film which was encircled the trunk of the animal. Moderate to severe erythema and edema were present in all cases but edema was greatly reduced by the second day after dosing, and has subsided almost completely by the third day. Erythema persisted to a slight degree a day or two longer. Apart from varying degrees of depression, most animals gave no evidence of systemic toxicity on the day following that of application of the dose. There were two deaths in the 10000 mg/kg group, and one death at the 5000 mg/kg level. LD50 was greater than 2500 mg/kg bw. Survivors’ results, were observed for a total of seven days after that of the dose, and were than sacrificed. No significant pathology was find by gross autopsy.
In conclusion, there is no acute dermal toxicity hazard as LD50 is >2000 mg/kg bw (active ingredient). Further information supporting the absence of acute toxicity potential is provided in the read across justification for the Di-ester category, showing that all substances in the group were negative for acute dermal toxicity (justification with data matrix separately attached in Section 13).
Acute inhalation toxicity
The registered substance has a vapour pressure of 25 Pa (20°C) and is marketed only in non solid and non granular form, i.e., as liquid. Inhalation is unlikely and acute inhalation testing would not lead to better risk assessment, therefore the study was waived based on Column 2 (Paragraph 8.5.2) in REACH legislation 2006R1907 Annex VIII.
Justification for selection of acute toxicity – oral endpoint
Key studty
Justification for selection of acute toxicity – dermal endpoint
Key study
Justification for classification or non-classification
As LD50 values were above limit dose of 2000 mg/kg bw for oral and dermal application, classifiation is not warranted according to the CLP regulation (No. 1272/2008 of 16 December 2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.